1. Pink Sheet

Opioid Litigation Avalanche: New York's Expanded Suit Puts More Pressure On Makers And Distributors

 
• By Brenda Sandburg

Complaint claims Sackler family transferred opioid profits to personal trusts; trials scheduled in federal multidistrict litigation and several state cases.

New York Attorney General Letitia James, March 019

New York Attorney General Letitia James makes new allegations against opioid makers and distributors in an amended complaint that could intensify the pressure on them to settle the ever-growing flood of litigation.

James announced the filing of the complaint at a March 28 press conference, calling it the "nation's most extensive lawsuit" against manufacturers and distributors of opioid products. Like the more than 1,500 suits that have been filed against opioid makers, this one alleges deceptive marketing by six manufacturers

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal & IP

More from Pink Sheet

EU Shaping Biotech Act To Unleash SME Potential

 
• By Neena Brizmohun

European companies, in particular small and midsize enterprises, spin-offs and start-ups have a hard time expanding within the single market “because of a complex regulatory framework that is perceived as slow and burdensome,” according to the European Commission.

New EU Filings

 
• By Neena Brizmohun

Brensocatib, Insmed's investigational treatment for non-cystic fibrosis bronchiectasis, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

‘Tectonic’ Arkansas PBM Legislation May Upend Industry

 
• By Tim Casey

Industry will fight hard to prevent other states or the federal government from adopting measures similar to Arkansas' law preventing PBMs from owning pharmacies.